The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(2-(3-nitrobenzylidene)hydrazinyl)benzenesulfonic acid ID: ALA3929420
Chembl Id: CHEMBL3929420
PubChem CID: 9578886
Max Phase: Preclinical
Molecular Formula: C13H11N3O5S
Molecular Weight: 321.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=[N+]([O-])c1cccc(/C=N/Nc2ccc(S(=O)(=O)O)cc2)c1
Standard InChI: InChI=1S/C13H11N3O5S/c17-16(18)12-3-1-2-10(8-12)9-14-15-11-4-6-13(7-5-11)22(19,20)21/h1-9,15H,(H,19,20,21)/b14-9+
Standard InChI Key: SAVFSAFMBXOSBY-NTEUORMPSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 321.31Molecular Weight (Monoisotopic): 321.0419AlogP: 2.29#Rotatable Bonds: 5Polar Surface Area: 121.90Molecular Species: ACIDHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: -2.64CX Basic pKa: 3.94CX LogP: 1.53CX LogD: 0.55Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.38Np Likeness Score: -1.75
References 1. (2013) Heme oxygenase inhibitors, screening methods for heme oxygenase inhibitors and methods of use of heme oxygenase inhibitors for antimicrobial therapy,